Canada markets open in 3 hours 52 minutes

GeneLink, Inc. (GNLKQ)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.0000+0.0000 (+900.00%)
At close: 03:48PM EDT

GeneLink, Inc.

8240 Exchange Drive
Suite C1
Orlando, FL 32809
United States
407-680-1150
https://www.genelinkbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Bernard L. Kasten Jr., Ph.D., M.D.Executive Chairman, Chief Executive Officer, President and Member of Scientific Advisory Board23.72kN/A1946
Dr. Robert P. RicciardiFounder, Chief Science Officer, Treasurer, Secretary, Director & Member of Scientific Advisory Board30kN/A1947
Mr. Michael G. SmithCOO & Interim CFON/AN/A1966
Amounts are as of December 31, 2008 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

Corporate Governance

GeneLink, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.